Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Ra Capital Management, L.P. reported a 9.90% stake in Mineralys Therapeutics, Inc. (Schedule 13D/A)

Event Mar 13, 2025 · Filed Mar 17, 2025

Ra Capital Management, L.P. reported a 9.90% stake in Mineralys Therapeutics, Inc., 6,287,597 shares, with active intent on Mar 13, 2025. Filed Mar 17, 2025 (Schedule 13D/A).

Stake
9.90%
Shares
6,287,597
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%6,287,597
Peter Kolchinsky9.90%6,287,597
Rajeev Shah9.90%6,287,597
RA Capital Healthcare Fund, L.P.6.90%4,358,979

Source

View original at SEC

Related